Search Results - "Hussain, Shamas"

Efficacy and Safety of Elective Switching from Intravenous to Subcutaneous Infliximab [CT-P13]: A Multicentre Cohort Study by Smith, Philip J, Critchley, Lisa, Storey, Daniel, Gregg, Belle, Stenson, June, Kneebone, Andrew, Rimmer, Tracy, Burke, Stevena, Hussain, Shamas, Yi Teoh, Wan, Vazeille, Stephan, Serna, Solange, Steel, Alan, Derbyshire, Edmund, Collins, Paul, Dibb, Martyn, Flanagan, Paul, Probert, Christopher, Verma, Ajay M, Subramanian, Sreedhar

“…Abstract Background Intravenous [IV] infliximab is a well-established therapy for inflammatory bowel diseases [IBD] patients. A subcutaneous [SC] formulation…”
Get full text

405: EFFICACY AND SAFETY OF ELECTIVE SWITCHING OF INFLAMAMTORY BOWEL DISEASE PATIENTS FROM INTRAVENOUS TO SUBCUTANEOUS INFLIXIMAB: A MULTI-CENTRE COHORT STUDY by Smith, Philip J., Critchley, Lisa, Storey, Daniel, Gregg, Belle, Stenson, June E., Kneebone, Andrew, Rimmer, Tracy, Burke, Stevena E., Hussain, Shamas, Teoh, Wan Yi, Vazeille, Stephan, Serna, Solange, Steel, Alan, Derbyshire, Edmund, Collins, Paul, Dibb, Martyn, Flanagan, Paul K., Probert, Christopher, Verma, Ajay M., Subramanian, Sreedhar

Get full text

Efficacy and Safety of Elective Switching From Intravenous to Subcutaneous Infliximab (Ct-P13): A Multi-Centre Cohort Study by Smith, Philip J, Critchley, Lisa, Storey, Daniel, Gregg, Belle, Stenson, June, Kneebone, Andrew, Rimmer, Tracy, Burke, Stevena, Hussain, Shamas, Teoh, Wan Yi, Vazeille, Stephan, Serna, Solange, Steel, Alan, Derbyshire, Edmund, Collins, Paul, Dibb, Martyn, Flanagan, Paul, Probert, Christopher, Verma, Ajay M, Subramanian, Sreedhar

“…Intravenous (IV) infliximab is a well-established therapy for inflammatory bowel diseases (IBD) patients. A subcutaneous (SC) formulation of infliximab…”
Get full text